A phase IB study of NGR-hTNF in combination with doxorubicin in patients affected by advanced or metastatic solid tumors.
Phase of Trial: Phase I
Latest Information Update: 28 Jan 2013
At a glance
- Drugs Doxorubicin (Primary) ; NGR-TNF (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 14 Apr 2009 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.
- 14 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Apr 2009 Actual initiation date changed from Mar 2006 to Jan 2006 as reported by ClinicalTrials.gov.